Literature DB >> 8249154

Do the K+ channel openers relax smooth muscle by opening K+ channels?

U Quast1.   

Abstract

During the past decade, a group of chemically heterogeneous compounds known as the K+ channel openers has emerged. These compounds open a certain class of K+ channels (ATP-sensitive K+ channels) in the sarcolemma of vascular smooth muscle cells, which leads to hyperpolarization of the cell membrane and relaxation of the tissue. The mechanisms by which hyperpolarization affects smooth muscle contraction and contractility can thus be examined. Hyperpolarization induced by these K+ channel openers prevents Ca2+ entry through voltage-operated Ca2+ channels. Surprisingly, and by mechanisms not yet defined, hyperpolarization of the cell also reduces agonist-induced accumulation of inositol 1,4,5-trisphosphate (and consequently, Ca2+ mobilization from intracellular stores), and the Ca2+ sensitivity of the contractile apparatus. In addition, recent evidence reviewed here by Ulrich Quast suggests that the K+ channel openers possess further mechanisms of vasorelaxation not linked to the opening of plasmalemmal K+ channels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8249154     DOI: 10.1016/0165-6147(93)90006-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  40 in total

1.  The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

Authors:  Damian Stephan; Eva Stauss; Ulf Lange; Holger Felsch; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Russ; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

2.  Potassium channel agonists modify the local anaesthetic activity of bupivacaine in mice.

Authors:  M Gantenbein; L Attolini; B Bruguerolle
Journal:  Can J Anaesth       Date:  1996-08       Impact factor: 5.063

Review 3.  ATP-sensitive K+ channels in the kidney.

Authors:  U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 4.  High-conductance calcium-activated potassium channels; structure, pharmacology, and function.

Authors:  G J Kaczorowski; H G Knaus; R J Leonard; O B McManus; M L Garcia
Journal:  J Bioenerg Biomembr       Date:  1996-06       Impact factor: 2.945

5.  Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin.

Authors:  Francisco Orallo; Ezequiel Alvarez; Hélène Basaran; Claire Lugnier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-17       Impact factor: 3.000

6.  Polyunsaturated fatty acids are potent neuroprotectors.

Authors:  I Lauritzen; N Blondeau; C Heurteaux; C Widmann; G Romey; M Lazdunski
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

7.  Multiple mechanisms in the smooth muscle relaxant action of calcitonin gene-related peptide (CGRP) in the guinea-pig ureter.

Authors:  C A Maggi; S Giuliani; P Santicioli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

8.  Time-dependent fading of the activation of KATP channels, induced by aprikalim and nucleotides, in excised membrane patches from cardiac myocytes.

Authors:  D Thuringer; I Cavero; E Coraboeuf
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

9.  Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning.

Authors:  C Heurteaux; I Lauritzen; C Widmann; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Cromakalim inhibits transmitter acetylcholine release in rat trachea by an action on epithelial cells and a diffusible factor.

Authors:  Ross Vlahos; Maurice E Fabiani; David F Story
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-18       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.